久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

上海非利加實(shí)業(yè)有限公司Logo

熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥

當(dāng)前位置: 首頁(yè) > 所有品牌 > Ablynx
Ablynx
Ablynx Ablynx

比利時(shí)Ablynx  
Ablynx (歐洲證券交易所: ABLX) 是一家生物制藥公司,致力于研究和開發(fā)納米抗體,納米抗體是一類新型治療性蛋白,含有自然產(chǎn)生的單域抗體的獨(dú)特結(jié)構(gòu)和功能特性,用于治療一系列嚴(yán)重的,危害生命的人類疾病,包括炎性疾病,血栓,腫瘤和肺部疾病。今天,公司擁有多達(dá)25個(gè)新產(chǎn)品項(xiàng)目,其中7個(gè)納米抗體已應(yīng)用于臨床開發(fā)。Ablynx正與某些大型醫(yī)藥公司進(jìn)行成果卓越的研究合作.其中包括勃林格殷格翰,默克雪蘭諾,諾華和輝瑞。公司總部設(shè)在比利時(shí)根特,現(xiàn)有員工280多名。

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies?, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has over 25 projects in the pipeline and seven Nanobodies in clinical development.
To date, Ablynx has generated Nanobodies against more than 235 different disease targets and has characterised potent antagonists in vitro against 38 different targets. The Company and its collaborators have obtained positive in vivo efficacy data from animal studies in eight major therapeutic programmes in five disease areas.
Ablynx’s in-house lead programmes in the clinic, ATN-103, ALX-0081+ALX-0681, and ALX-0061 are in Phase II clinical development. ATN-103, is a subcutaneously administered, half-life extended Nanobody targeting TNF-alpa. In May 2011, it achieved positive clinical proof-of-concept in a Phase II study in patients with active rheumatoid arthritis. ALX-0081 and ALX-0681 are Nanobodies targeting von Willebrand factor (vWF), delivered intravenously (ALX-0081) and via a subcutaneous injection (ALX-0681), and are being evaluated in patients with thrombotic thrombocytopenic purpura (TTP). ALX-0061 is a half-life extended Nanobody that binds with high affinity to IL-6 receptor, both the soluble and membrane-bound form. It is currently in Phase II clinical trials in patients with rheumatoid arthritis.
Ablynx’s clinical development programme ALX-0141 has recently completed Phase I trials. ALX-0141 has been developed to inhibit bone loss associated with post-menopausal osteoporosis, rheumatoid arthritis, cancer and certain drugs.
Another Nanobody in clinical development is ATN-192 (formerly known as PF-05230905), and Phase I results are expected during the first half of 2012.
Finally, in December 2011, a Phase I study with the first inhaled Nanobody, ALX-0171, was initiated. ALX-0171 has the potential to be a first-in-class therapeutic to treat respiratory syncytial viral infections (RSV).
In parallel with its internally developed products, Ablynx has ongoing research collaborations and significant partnerships with major pharmaceutical companies, including Boehringer Ingelheim, Merck Serono, and Novartis. Ablynx is building a diverse and broad portfolio of therapeutic Nanobodies through these collaborations.
Ablynx has a strong and broad IP position and is the only company in the world with rights in the field of therapy and diagnosis under the granted US and European patents that describe the composition of matter of Nanobodies (the “Hamers patents”), representing a distinct and unique position in the complex field of antibody-derived therapeutics. Nanobody? is a registered trademark of Ablynx NV.

關(guān)于我們客戶服務(wù)產(chǎn)品分類法律聲明
主站蜘蛛池模板: 一区二区三区成人 | 欧美另类日韩中文色综合 | 久青草国产视频 | 久久久久久综合一区中文字幕 | 欧美视频日韩专区午夜 | 一本色道久久88综合亚洲精品高清 | 亚洲欧美在线观看视频 | 永久免费观看的毛片的网站下载 | a一区二区三区视频 | 日韩欧美一区二区三区在线视频 | 日本黄 色 成 年 人免费观看 | 久久久久九九 | 日韩欧美一区二区三区四区 | 亚洲欧美日韩激情在线观看 | 亚洲全黄| 国产手机在线精品 | 韩国精品一区 | 91精品国产色综合久久不卡蜜 | 日韩毛片在线 | 天天做夜夜做久久做狠狠 | 国产亚洲午夜精品a一区二区 | 免费在线国产视频 | 亚洲精品第一页 | 国产日韩欧美高清 | 国产综合在线视频 | 亚洲免费久久 | 图片一区| 国产精品专区第二 | 国产在线视欧美亚综合 | 国产自在线拍 | 在线v片 | 黄毛片| 欧美一区二区在线免费观看 | 国产一级高清视频免费看 | 欧美视频日韩专区午夜 | 久久免费精品国产72精品剧情 | 久久精品国产99久久99久久久 | 亚洲精品毛片久久久久久久 | 欧美日韩国产一区二区三区 | 国产精品亚洲色图 | 日韩色网|